The effect of prednisone treatment on lung function test parameters in patients with chronic sarcoidosis

V. Zugic, V. Vucinic, J. Ivanov (Belgrade, Yugoslavia)

Source: Annual Congress 2002 - Sarcoidosis
Session: Sarcoidosis
Session type: Poster Discussion
Number: 2748
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Zugic, V. Vucinic, J. Ivanov (Belgrade, Yugoslavia). The effect of prednisone treatment on lung function test parameters in patients with chronic sarcoidosis. Eur Respir J 2002; 20: Suppl. 38, 2748

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A comparison of the effects of lung function between low dose theophylline and oral β2-agonist in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 215s
Year: 2006

Effect of infliximab on lung function and well-being in patients with refractory sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

The effect of HIV-associated tuberculosis, tuberculosis-IRIS and prednisone on lung function
Source: Eur Respir J, 55 (3) 1901692; 10.1183/13993003.01692-2019
Year: 2020



The effects of oral corticosteroid treatment (OCS) on sequential lung function tests in a cohort of patients with acute hypersensitivity pneumonitis (AHP)
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020


The effect of long term low dose azithromycin on symptoms and lung function in pulmonary sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008



Effect of low dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): results from a real life study
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021


The course of COVID-19 in pulmonary sarcoidosis patients, receiving methotrexate
Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis
Year: 2021


Long-term response to prednisone in newly treated patients with pulmonary sarcoidosis
Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Year: 2021



Effect of long-term bronchodilator therapy on pulmonary function tests and exercise tolerance in patients with stable chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 246s
Year: 2002

The positive effect of cilomilast on lung function in patients with chronic obstructive pulmonary disease (COPD) is independent of patient smoking status
Source: Eur Respir J 2002; 20: Suppl. 38, 620s
Year: 2002

Effect of omeprazol on pulmonary function test in asthmatic patients
Source: Eur Respir J 2006; 28: Suppl. 50, 316s
Year: 2006

The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

The effect of oral corticosteroids on spirometric parameters in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008

The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 295s
Year: 2005

Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids
Source: Eur Respir J 2001; 17: 337-342
Year: 2001



The association between lung function and exacerbation frequency in patients with COPD, results from a systemic review
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009

Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: management
Year: 2010


The effect preoperative intervention with long-acting bronchodilator for untreated patients with obstructive lung disease
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018


The bronchodilator test in patients with chronic airway obstruction: the responsiveness of lung function parameters
Source: International Congress 2018 – Respiratory physiology and measurements
Year: 2018

Effect of metformin on clinically relevant outcomes in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017